Cactus, Inc. (WHD) Q4 2025 Earnings Call Transcript

Nuveen Churchill Direct Lending Corp. (NCDL) Q4 2025 Earnings Call Transcript

The J. M. Smucker Company (SJM) Q3 2026 Earnings Call Transcript

PSX's diversified model may outshine CVE as soft oil prices pressure upstream earnings and reshape energy investment appeal.

Pre-market indexes are swinging back into positive territory from lower early-morning levels, now erasing the big losses in the first part of this week on all but the small-cap Russell 2000, which is break-even over the past five trading days. This morning, the Dow is +110 points, +0.22%, the S&P 500 is +6, +0.09%, the Nasdaq +7, +0.03% and the Russell 2000 +4, +0.18%.

LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Navan, Inc. (NAVN) Shareholders To Inquire About Securities Fraud Class Action.

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Lakeland Industries, Inc. (LAKE) Shareholders To Inquire About Securities Fraud Class Action.

Block & Leviton is investigating Eos Energy Enterprises, Inc. (Nasdaq: $EOSE) for potential securities law violations. Investors should contact the firm.

BOSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Alight, Inc. (NYSE: ALIT) for potential securities law violations. Investors who have lost money in their Alight, Inc. investment should contact the firm to learn more about how they might recover those losses.

Super Micro is rated 'Buy' due to strong AI server demand, unique solutions, and undervaluation despite margin compression. SMCI's modular design and DLC scale enable it to launch NVIDIA Blackwell systems four weeks ahead of the competition. Trading at a 42.9% EV/Sales discount to peers, SMCI offers a conservative target of $37 and a bullish recovery potential to $62.

Ahead of Dell Technologies' (DELL) earnings after Thursday's close, Jim Kelleher explains the tailwinds and headwinds facing the legacy tech company into its report. The tailwinds: strong PC and AI server businesses.

Arcutis Biotherapeutics delivered a strong Q4 2025, with $127.5M in revenue (+84% YoY) and a GAAP EPS beat, driven by Zoryve's rapid adoption. ARQT is transitioning from a launch-stage biotech to a profitable, high-growth commercial company, with Zoryve now the leading branded nonsteroidal topical in its indications. Valuation is premium at ~9x forward EV/sales but justified by operating leverage, a robust pipeline, and upcoming pediatric/label expansion catalysts.

BENSALEM, Pa., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G.

LOS ANGELES, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming April 7, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Paysafe Limited (“Paysafe” or the “Company”) (NYSE: PSFE) securities between March 4, 2025 and November 12, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR PAYSAFE INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.

LOS ANGELES, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming March 2, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) securities between February 26, 2025 and August 4, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. (NASDAQ: INO) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Inovio securities between October 10, 2023 and December 26, 2025, both dates inclusive (the “Class Period”).

LOS ANGELES, Feb. 26, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Fermi Inc. ("Fermi" or the "Company") (NASDAQ: FRMI) have opportunity to lead the securities fraud class action lawsuit.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025, inclusive (the “Class Period”). Corcept investors have until April 21, 2026 to file a lead plaintiff motion. IF YO.

Shareholders with losses of $50,000 or more are encouraged to contact the firm. LOS ANGELES, Feb. 26, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Plug Power, Inc. ("Plug Power" or the "Company") (NASDAQ: PLUG).